ArticleThe Journal of rheumatology2016

Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.

Laura Durcan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.